The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial (Cardiac Output Study)
Condition(s) studied
Investigational drug(s) / intervention(s)
Philips Advanced Monitoring Cuff (AMC): The Philips AMC is a Class II (USA) and Class IIb (EU) medical device that is a non-invasive, semirigid disposable upper arm cuff with an integrated pneumatic actuator enabling hydraulic coupling of tissue pressure waveforms from the upper arm tissue.
Study summary
The purpose of this study is to compare cardiac output (CO), fluid responsiveness, and related measurements between the Philips AMC and PAC (Swan-Ganz) in ICU or surgical patients.
Eligibility
Primary outcome measure(s)
- Primary Endpoints — Approximately 8 months for accrual and follow-up
The comparison of cardiac output between the Philips AMC and PAC
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| UVA Health | Charlottesville | Virginia | Recruiting |
| Universitätsklinikum Hamburg Eppendorf | Hamburg | Free and Hanseatic City of Hamburg | Recruiting |
More Philips Clinical & Medical Affairs Global trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06895603 on ClinicalTrials.gov ↗ ← All trials in the USA